Haemophilus influenzae invasive disease in the United States, 1994- 1995: Near disappearance of a vaccine-preventable childhood disease

Emerging Infectious Diseases

Volumn 4, Issue 2, 1998, Pages 229-237

  Bisgard, Kristine M ^a   Kao, Annie ^a   Leake, John ^a   Strebel, Peter M ^a   Perkins, Bradley A ^a   Wharton, Melinda ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ADOLESCENT; ADULT; AGED; CELL INVASION; CHILD; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; NEWBORN; REVIEW; SERODIAGNOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED STATES; VACCINATION;

EID: 0031834394     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0402.980210     Document Type: Review

References (33)

1. Cochi SL, Broome CV, Hightower AW. Immunization of U.S. children with Haemophilus influenzae type b polysaccharide vaccine: a cost-effectiveness model of strategy assessment. JAMA 1985;253:521-9.
2. Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, et al. Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992;14:568-79.
3. Centers for Disease Control and Prevention. Progress towards elimination of Haemophilus influenzae type b disease among infants and children - United States, 1987-1995. MMWR Morb Mortal Wkly Rep 1996;45:901-6.
4. Adams WG, Deaver KA, Cochi SL, Plikaytis BE, Bell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269:221-6.
5. Centers for Disease Control. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1991;40(RR-1):1-6.
6. Centers for Disease Control and Prevention. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis and Haemophilus type b vaccine: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1993;42(RR-13):1-15.
7. Centers for Disease Control and Prevention. Reported vaccine-preventable disease - United States, 1993, and the Childhood Immunization Initiative. MMWR Morb Mortal Wkly Rep 1994;43:57-60.
8. Farley MM, Stephen DS, Brachman PS, Harvey C, Smith JD, Wenger JD, et al. Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. Ann Intern Med 1992;116:806-12.
9. Takala AK, Eskola J, van Alpen L. Spectrum of invasive Haemophilus influenzae type b disease in adults. Arch Intern Med 1990;150:2573-6.
10. Steinhart R, Reignold AL, Taylor F, Anderson G, Wenger JD. Invasive Haemophilus influenzae infections in men with HIV infection. JAMA 1992;268:3350-2.
11. Kostman JR, Sherry BL, Filgner CL, Egaas S, Sheeran P, Baken L, et al. Invasive Haemophilus influenzae infections in older children and adults in Seattle. Clin Infect Dis 1993;17:389-96.
12. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997;46(RR-10):15.
13. Resident population - estimates by age, sex, and Hispanic origin. Washington: U.S. Dept. of Commerce, Bureau of the Census, Population Division; 1995 July. Appendix A.
14. Technical notes: nature and sources of data. Hyattsville (MD): Centers for Disease Control and Prevention, National Center for Health Statistics; 1992. Monthly vital statistics report 41:21.
15. Atlas GIS Software (computer program). Arlington (VA): ATLAS Software, Claritas, Inc.; (Au: give date).
16. Centers for Disease Control and Prevention. Vaccination coverage levels of 2-year-old children - United States, January-March 1994. MMWR Morb Mortal Wkly Rep 1995;44:142-50.
17. Centers for Disease Control and Prevention. National, state, and urban area vaccination coverage levels among children aged 19-35 months - United States, January-December 1995. MMWR Morb Mortal Wkly Rep 1997;46:176-82.
18. Ward J, Leiberman JM, Cochi SL. Haemophilus influenzae vaccines. Vaccines. 2nd ed. In: Plotkin SA, Mortimer EA, editors. Philadelphia: WB Saunders Co. 1994;337-86.
19. Murphy TV, Osterholm MT, Pierson LM, White KE, Breedlove LVN, Siebert GB, et al. Prospective surveillance of Haemophilus influenzae type b disease in Dallas County, Texas and in Minnesota. Pediatr 1987;79:173-80.
20. Ward JI, Lum MKW, Hall DB, Silimperi DR, Bender TR. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis 1986;153:17-26.
21. Cochi SL, Fleming DW, Hightower AW, Limpakarnjanarat K, Facklam RR, Smith JD, et al. Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr 1986;108:887-96.
22. Granoff DM, Basdon M. Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J Infect Dis 1980;141:40-6.
23. Standaert SM, Lefkowitz LB, Horan JM, Hutcheson RH, Schaffner W. The reporting of communicable diseases: a controlled study of Neisseria meningitidis and Haemophilus influenzae infections. Clin Infect Dis 1995;20:30-6.
24. Galil K, Singleton R, Levine O, Fitzgerald M, Ajello G, Bulkow L, Parkinson A. High prevalence of Haemophilus influenzae type b (Hib) carriage among Alaska Natives despite widespread use of Hib conjugate vaccine. In: Abstracts of the 35th Infectious Disease Society of America; San Francisco, California; 1997 Sep 13-16; Abstract 421. Alexandria (VA): Infectious Disease Society of America; 1997.
25. Mohle-Boetani JC, Ajello G, Breneman E, Deaver KA, Harvey C, Plikaytis BD, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 1993;12:589-93.
26. Barbour ML. Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis 1996;3:176-82.
27. Farley MM, Baughman W, Robinson K, Facklam R, Schuchat A, Wenger JD. Elimination of invasive Haemophilus influenzae type b (Hib) disease in adults in Atlanta through immunization of children with conjugate Hib vaccine. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; Toronto, Canada. Abstract K-150. Washington: American Society for Microbiology, Washington; 1997. p. 352.
28. Jafari H, Adams W, Deaver K, Plikaytis B, Wenger J. Efficacy of Haemophilus influenzae Type b (Hib) conjugate vaccine, risk factors for invasive Hib disease and under-vaccination in the United States. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, California; 1995; Abstract # G12. Washington: American Society for Microbiology; 1995. p. 160.
29. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination coverage by age 2 years - linkage of vaccination and WIC services. MMWR Morb Mortal Wkly Rep 1996;45:217-8.
30. Campbell JR, Szilagyi PG, Rodewald LE, Doane C, Roghmann KJ. Patient-specific reminder letters and pediatric well-child-care show rates. Clin Pediatr (Phila) 1994;May:268-72.
31. Abramson JS, O'Shea MO, Ratledge DL, Lawless MR, Givner LB. Development of a vaccine tracking system to improve the rate of age-appropriate primary immunization in children of lower socioeconomic status. J Pediatr 1995;126:583-6.
32. Dini EF, Linkins RW, Chaney M. Effectiveness of computer-generated telephone messages in increasing clinic visits. Arch Pediatr Adolesc Med 1995;149:902-5.
33. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination rates - assessment and feedback of provider-based vaccination coverage information. MMWR Morb Mortal Wkly Rep 1996;45:219-20.